Patients who received IC were younger, with more frequent t -AML or neo-AML, higher BM blast cells percentage, and more favorable cytogenetics, and they showed a trend to have more NPM1 mutations.
← all excerpts
Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study.
1
—
—